Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study).

Otten, J

Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study). [electronic resource] - Cancer chemotherapy and pharmacology 1989 - S30 p. digital

Publication Type: Clinical Trial; Journal Article

0344-5704

10.1007/BF00253236 doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Child
Clinical Trials as Topic
Dactinomycin--administration & dosage
Humans
Ifosfamide--administration & dosage
Mesenchymoma--drug therapy
Rhabdomyosarcoma--drug therapy
Vincristine--administration & dosage